Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 16:10 ET | Source: OncoCyte Corporation

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025
April 02, 2025 08:45 ET | Source: OncoCyte Corporation

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
February 11, 2025 08:30 ET | Source: OncoCyte Corporation

Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 08, 2025 08:30 ET | Source: OncoCyte Corporation

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
October 08, 2024 08:30 ET | Source: OncoCyte Corporation

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Results published in peer-reviewed journal, Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO...
May 30, 2024 16:47 ET | Source: OncoCyte Corporation

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...